Amantadine HCl Capsules, USP, 100 mg, Rx Only, 50 Capsules (5x10) Unit Dose Cartons, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0069-15
Published August 9, 2017 · Recall initiated: June 19, 2017
Summary
FDA records drug Class II recall D-1035-2017, published August 9, 2017 and initiated June 19, 2017. Recalling firm: Apace KY LLC; Status: Terminated; Reported quantity: 1,483 cartons; Lot: Lot: 16710, exp 07/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Apace KY LLC
- Distributor
- KY
- Lot
- Lot: 16710, exp 07/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAcyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDCMarch 7, 2018
- FDACyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKAREAugust 9, 2017
- FDAINVUITY(R) PhotonBlade(TM), REF PB1August 2, 2017
- FDASTOCKERT Heater-Cooler System 3T, 120V/60 HzAugust 2, 2017
- FDAMinocycline Hydrochloride Capsules USP, 100 mg*, 30 Capsules (3 x 10) Unit Dose blisters (NDC 50268-569-11,April 13, 2016
- FDAEnalapril Maleate Tablet, USP 5mg 30 Tablet bottle, Rx, Apace Packaging LLC, Ft. Run, KY 42133, NDCSeptember 26, 2012
Questions about this recall
Was Amantadine HCl Capsules, USP, 100 mg, Rx Only, 50 Capsules (5x10) Unit Dose Cartons, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0069-15 recalled?
Yes. FDA published recall D-1035-2017 on August 9, 2017. Reported hazard: Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail